Logo image of FGNX

FUNDAMENTAL GLOBAL INC (FGNX) Stock Fundamental Analysis

NASDAQ:FGNX - US30329Y3045 - Common Stock

9.63 USD
-0.64 (-6.23%)
Last: 9/5/2025, 8:13:01 PM
9 USD
-0.63 (-6.54%)
After Hours: 9/5/2025, 8:13:01 PM
Fundamental Rating

2

FGNX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 146 industry peers in the Insurance industry. FGNX may be in some trouble as it scores bad on both profitability and health. FGNX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

FGNX had negative earnings in the past year.
FGNX had a negative operating cash flow in the past year.
FGNX had negative earnings in 4 of the past 5 years.
In the past 5 years FGNX always reported negative operating cash flow.
FGNX Yearly Net Income VS EBIT VS OCF VS FCFFGNX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

1.2 Ratios

FGNX has a Return On Assets of -8.25%. This is amonst the worse of the industry: FGNX underperforms 91.10% of its industry peers.
Looking at the Return On Equity, with a value of -12.89%, FGNX is doing worse than 88.36% of the companies in the same industry.
Industry RankSector Rank
ROA -8.25%
ROE -12.89%
ROIC N/A
ROA(3y)-0.21%
ROA(5y)-18.87%
ROE(3y)-0.16%
ROE(5y)-20.05%
ROIC(3y)N/A
ROIC(5y)N/A
FGNX Yearly ROA, ROE, ROICFGNX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for FGNX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
FGNX Yearly Profit, Operating, Gross MarginsFGNX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 2K 4K 6K

More info and screens

3

2. Health

2.1 Basic Checks

FGNX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for FGNX has been increased compared to 1 year ago.
FGNX has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, FGNX has a worse debt to assets ratio.
FGNX Yearly Shares OutstandingFGNX Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
FGNX Yearly Total Debt VS Total AssetsFGNX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

FGNX has an Altman-Z score of 0.15. This is a bad value and indicates that FGNX is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of FGNX (0.15) is better than 67.81% of its industry peers.
A Debt/Equity ratio of 0.05 indicates that FGNX is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.05, FGNX belongs to the top of the industry, outperforming 84.25% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 0.15
ROIC/WACCN/A
WACC8.16%
FGNX Yearly LT Debt VS Equity VS FCFFGNX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

A Current Ratio of 0.47 indicates that FGNX may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.47, FGNX is in the better half of the industry, outperforming 74.66% of the companies in the same industry.
FGNX has a Quick Ratio of 0.47. This is a bad value and indicates that FGNX is not financially healthy enough and could expect problems in meeting its short term obligations.
FGNX has a Quick ratio of 0.47. This is in the better half of the industry: FGNX outperforms 74.66% of its industry peers.
Industry RankSector Rank
Current Ratio 0.47
Quick Ratio 0.47
FGNX Yearly Current Assets VS Current LiabilitesFGNX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 31.23% over the past year.
The Revenue has grown by 51.88% in the past year. This is a very strong growth!
The Revenue has been growing by 41.74% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)31.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.67%
Revenue 1Y (TTM)51.88%
Revenue growth 3YN/A
Revenue growth 5Y41.74%
Sales Q2Q%29.61%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FGNX Yearly Revenue VS EstimatesFGNX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M
FGNX Yearly EPS VS EstimatesFGNX Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 5 10

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

FGNX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FGNX Price Earnings VS Forward Price EarningsFGNX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FGNX Per share dataFGNX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for FGNX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FUNDAMENTAL GLOBAL INC

NASDAQ:FGNX (9/5/2025, 8:13:01 PM)

After market: 9 -0.63 (-6.54%)

9.63

-0.64 (-6.23%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)08-07 2025-08-07
Earnings (Next)11-12 2025-11-12
Inst Owners34.15%
Inst Owner ChangeN/A
Ins Owners12.31%
Ins Owner Change0.49%
Market Cap12.81M
AnalystsN/A
Price TargetN/A
Short Float %16.42%
Short Ratio0.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend1.67
Dividend Growth(5Y)N/A
DP-17.02%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.38
P/FCF N/A
P/OCF N/A
P/B 0.2
P/tB 0.2
EV/EBITDA N/A
EPS(TTM)-5.58
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-5.02
FCFYN/A
OCF(TTM)-4.99
OCFYN/A
SpS25.25
BVpS48.24
TBVpS48.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.25%
ROE -12.89%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-0.21%
ROA(5y)-18.87%
ROE(3y)-0.16%
ROE(5y)-20.05%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 5.74%
Cap/Sales 0.12%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.47
Quick Ratio 0.47
Altman-Z 0.15
F-Score3
WACC8.16%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)4.97%
Cap/Sales(5y)4.35%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)31.23%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.67%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)51.88%
Revenue growth 3YN/A
Revenue growth 5Y41.74%
Sales Q2Q%29.61%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-4313.14%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-13.78%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-12.69%
OCF growth 3YN/A
OCF growth 5YN/A